BioCentury
ARTICLE | Clinical News

Debrase gel dressing: Phase III started

February 13, 2006 8:00 AM UTC

MediWound started a Phase III trial. It will begin additional trials in the U.S. in 2006 and expects approval in Europe in 2007. DGD has Orphan Drug designations in the EU and U.S. ...